Komori
Dexerials (4980) · InitiativeAdvancedLatest Other Disclosures (2026-07-29): "Restated"

Continuation of Research and Development Activities

First written in FY2017-Q1. 25 of 38 entries say "Restated". Latest entry: 2026-07-29.

38entries
11years
5from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2017-Q1 – FY2019-Q3AdvancedFY2024 – FY20252016: 220162017: 320172018: 420182019: 420192020: 420202021: 420212022: 420222023: 320232024: 220242025: 220252026: 62026
Same theme, other companies
Research and Development and Commercialization of Optical Semiconductor SolutionsA theme 4 companies write about · 0 as a headwind · 8 as a tailwind

0 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. 2026-07-29RestatedOther Disclosures

    「By combining our six core technologies※5, we will accelerate the creation of new solutions in areas such as data centers, photonics and automotive applications, where growth is expected as AI becomes more widely adopted.」

    The company reaffirmed its direction of accelerating solution creation in AI, data centers, photonics and automotive applications.
  2. FY2026AdvancedAnnual report

    「In fiscal 2024, we formulated a technology strategy for medium-term growth and designated photonics and semiconductor integration as priority areas.」

    The priority areas for R&D were designated as photonics and semiconductor integration, and the company advanced exhibitions and market dialogue concerning waveguide photodiodes and surface-normal photodiodes. R&D expenses totaled ¥6,740 million.
  3. FY2026-H1RestatedAnnual report

    「The amount spent on the Group's R&D activities during the interim consolidated accounting period was ¥3,146 million. There were no material changes in the status of the Group's R&D activities during the interim consolidated accounting period.」

    R&D expenses of ¥3,146 million were recorded, with no material changes in the status of R&D activities.
  4. FY2025AdvancedAnnual report

    「We newly designated the following as our “six core technologies”: ① thin-film formation and coating technologies, ② microfabrication technologies, ③ optical semiconductor technologies, ④ inorganic materials technologies, ⑤ organic materials technologies, and ⑥ analytical and evaluation technologies.」

    R&D expenses totaled ¥5,330 million, and, in addition to the previous expansion of the technology portfolio, six core technologies were explicitly designated.
  5. FY2024AdvancedAnnual report

    「To expand our technology portfolio, we are advancing technology development focused on optical and compound semiconductor technologies and integration and heterogeneous bonding technologies. In creating products in new fields, we are working to commercialize optical communications and sensing products using these technologies.」

    R&D expenses totaled ¥4,706 million. The company explicitly disclosed plans to add optical and compound semiconductor technologies and integration and heterogeneous bonding technologies to its technology portfolio and advance the commercialization of optical communications and sensing products.
  6. FY2024-Q3RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative third quarter was ¥3,473 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    R&D expenses for the cumulative third quarter totaled ¥3,473 million, with no material changes in the status of R&D activities.
  7. FY2024-Q2RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative second quarter was ¥2,245 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    R&D expenses for the cumulative second quarter totaled ¥2,245 million, with no material changes in the status of R&D activities.
  8. FY2023AdvancedAnnual report

    「We are also actively investing in human resources and promoting open innovation, creating new “technology solutions” in addition to “products” in the form of materials and devices. To create new technologies, products and solutions in unexplored fields and at unprecedented levels, and to develop the next generation of talent in these fields, Dexerials has conducted joint research with Tohoku University since 2021 in areas including optics and semiconductors, with the aim of developing new technologies that contribute to solving social issues. On 1 April 2023, we newly established the “Dexerials × Tohoku University Optical Metasensing Co-Creation Research Institute.”」

    R&D expenses totaled ¥4,274 million, and a co-creation research institute to establish joint research with Tohoku University was newly established on 1 April 2023.
  9. FY2023-Q3RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative third quarter was ¥3,207 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    R&D expenses totaled ¥3,207 million, with no material changes in the status of R&D activities.
  10. FY2023-Q2RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative second quarter was ¥2,089 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    R&D expenses of ¥2,089 million were recorded, with no material changes in the status of R&D activities.
  11. FY2023-Q1RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative first quarter was ¥1,020 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    R&D expenses of ¥1,020 million were recorded, with no material changes in the status of R&D activities.
  12. FY2022AdvancedAnnual report

    「• Commercialized phosphor film “PS Series” • Developed a diffusive microlens array to improve the performance of automotive head-up displays • Commercialized lead-free model “SFJ 15 Ampere T Series” of the Self-Control Protector • Commercialized “PTA-036100” Power Current Protector, a compact, surface-mount high-current fuse • Commercialized “ZX11N,” a silicone-type thermally conductive sheet suitable for heat dissipation from IC chips in communication base stations, automobiles and other applications • Commercialized a shape-processed anisotropic conductive film (ACF) suitable for mounting components such as camera modules • Commercialized “Jettable SVR,” an optical elastomer resin compatible with inkjet application」

    R&D expenses totaled ¥3,876 million, and the development and commercialization of phosphor film, materials for automotive HUDs, high-current fuses, thermally conductive sheets, shape-processed ACF, and Jettable SVR, among others, were specifically disclosed.
  13. FY2022-Q3RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative third quarter was ¥2,748 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    R&D expenses of ¥2,748 million were recorded, with no material changes in the status of R&D activities.
  14. FY2022-Q2RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative second quarter was ¥1,765 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    R&D expenses of ¥1,765 million were recorded, with no material changes in the status of R&D activities.
  15. FY2022-Q1RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative first quarter was ¥861 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    R&D expenses of ¥861 million were recorded, with no material changes in the status of R&D activities.
  16. FY2021AdvancedAnnual report

    「• Commercialized “Infrastructure Aid™” UV-curable sealant “UVS-1000C,” effective for emergency repairs of oil leaks in electrical equipment such as transformers • Developed “AR Film HD Series” anti-reflection film, forming an antifouling layer by vacuum deposition and improving surface durability by more than 40 times • Developed “Jettable SVR,” an optical elastomer resin compatible with inkjet application • Developed and commercialized an aligned-particle anisotropic conductive film (ACF) with large conductive particles arranged in alignment」

    R&D expenses of ¥3,611 million were recorded, and the commercialization of UV-curable sealant, anti-reflection film with durability improved by more than 40 times, Jettable SVR, and aligned-particle ACF was specifically disclosed.
  17. FY2021-Q3RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative third quarter was ¥2,574 million. There were no material changes in the status of the Group's R&D activities during the cumulative third quarter.」

    R&D expenses of ¥2,574 million were recorded, with no material changes in the status of R&D activities.
  18. FY2021-Q2RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative second quarter was ¥1,707 million. There were no material changes in the status of the Group's R&D activities during the cumulative second quarter.」

    R&D expenses of ¥1,707 million were recorded, with no material changes in the status of R&D activities.
  19. FY2021-Q1RestatedAnnual report

    「The amount spent on the Group's R&D activities during the cumulative first quarter was ¥861 million. There were no material changes in the status of the Group's R&D activities during the cumulative first quarter.」

    R&D expenses of ¥861 million were recorded, with no material changes in the status of R&D activities.
  20. FY2020AdvancedAnnual report

    「また、企業や大学、公的研究機関とのオープンイノベーションも積極的に取り組み、研究開発の一層のスピードアップを目指しています。\n・5G通信などの高速伝送向けフレキシブルプリント基板の製造を容易にする低誘電ボンディングシートを開発\n・防曇防汚ソリューション「キレイア」がオムロン株式会社の反射形光電センサーに採用」

    In addition to R&D expenses of ¥3,653 million, specific results were disclosed, including the promotion of open innovation, development of low-dielectric bonding sheets for high-speed 5G transmission, and adoption of existing solutions.
  21. FY2020-Q3RestatedAnnual report

    「当第3四半期連結累計期間における当社グループの研究開発活動の金額は、2,733百万円であります。なお、当第3四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費2,733百万円を計上し、研究開発活動の状況に重要な変更はないとした。
  22. FY2020-Q2RestatedAnnual report

    「当第2四半期連結累計期間における当社グループの研究開発活動の金額は、1,806百万円であります。なお、当第2四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費1,806百万円を計上し、研究開発活動の状況に重要な変更はないとした。
  23. FY2020-Q1RestatedAnnual report

    「当第1四半期連結累計期間における当社グループの研究開発活動の金額は、896百万円であります。なお、当第1四半期連結累計期間において、当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費896百万円を計上し、研究開発活動の状況に重要な変更はないとした。
  24. FY2019AdvancedAnnual report

    「・汚れのとれやすさとくもりにくさを向上させる鏡向け防曇防汚ソリューションを開発、提供を開始」

    研究開発活動の状況に重要な変更はないという定型的な説明に加え、鏡向け防曇防汚ソリューションの提供開始、5G対応低誘電ボンディングシート等の開発成果を具体的に開示した。研究開発費は3,701百万円だった。
  25. FY2019-Q3RestatedAnnual report

    「当第3四半期連結累計期間における当社グループの研究開発活動の金額は、2,836百万円であります。なお、当第3四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費2,836百万円を計上し、研究開発活動の状況に重要な変更はないとした。
  26. FY2019-Q2RestatedAnnual report

    「当第2四半期連結累計期間における当社グループの研究開発活動の金額は、1,854百万円であります。なお、当第2四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費1,854百万円を計上し、研究開発活動の状況に重要な変更はないとされた。
  27. FY2019-Q1RestatedAnnual report

    「当第1四半期連結累計期間における当社グループの研究開発活動の金額は、939百万円であります。なお、当第1四半期連結累計期間において、当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費939百万円を計上し、研究開発活動の状況に重要な変更はないとされた。
  28. FY2018RestatedAnnual report

    「当社グループは、コア技術である材料技術、プロセス技術、設計技術、分析・解析技術、評価技術を融合、進化させることにより、技術基盤の強化とビジネス拡大への貢献を研究開発の基本方針とし、コーポレートR&D部門と商品開発本部が連携して開発活動を行っております。」

    研究開発の基本方針と体制が継続して示され、当連結会計年度の研究開発費は3,702百万円だった。
  29. FY2018-Q3RestatedAnnual report

    「当第3四半期連結累計期間における当社グループの研究開発活動の金額は、2,827百万円であります。なお、当第3四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費は2,827百万円と開示され、研究開発活動の状況に重要な変更はないとされた。
  30. FY2018-Q2RestatedAnnual report

    「当第2四半期連結累計期間における当社グループの研究開発活動の金額は、1,863百万円であります。なお、当第2四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費は1,863百万円で、研究開発活動の状況に重要な変更はないとされた。
  31. FY2018-Q1RestatedAnnual report

    「当第1四半期連結累計期間における当社グループの研究開発活動の金額は、888百万円であります。なお、当第1四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費は888百万円で、研究開発活動の状況に重要な変更はないとされた。
  32. FY2017-Q3RestatedAnnual report

    「当第3四半期連結累計期間における当社グループの研究開発活動の金額は、2,689百万円であります。なお、当第3四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費は2,689百万円で、研究開発活動の状況に重要な変更はないとされた。
  33. FY2017-Q2RestatedAnnual report

    「当第2四半期連結累計期間における当社グループの研究開発活動の金額は、1,839百万円であります。なお、当第2四半期連結累計期間において当社グループの研究開発活動の状況に重要な変更はありません。」

    研究開発費は1,839百万円で、活動状況に重要な変更はないとされた。
  34. FY2017-Q1First statedAnnual report

    「The Group’s research and development expenditures for the cumulative first quarter of the fiscal year were ¥946 million. There were no material changes in the Group’s research and development activities during the cumulative first quarter.」

    Research and development expenditures of ¥946 million were disclosed, with no material changes in research and development activities.
Moved together

"New production equipment begins operating at the Tochigi site" moved the same way as this thread, in the same document, in 8 of its 37 moves.

877655★123456
  1. ★This thread
  2. 1New production equipment begins operating at the Tochigi site8×
  3. 2Acquisition of Kyoto Semiconductor as a subsidiary and expansion into high-speed communications and sensing7×
  4. 3Increase in Shares and Capital Through the Exercise of Stock Acquisition Rights7×
  5. 4Increasing the market share of differentiated technology products and expanding applications for sputtered products6×
  6. 5Building an organization that supports transformation and developing next-generation talent and engineers5×
  7. 6Payment of dividends, including a listing commemorative dividend5×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Dexerials's next results are scheduled for 2026-11-11. Read the earnings preview It last moved in the Other Disclosures of 2026-07-29: "Restated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.